Differential DNA-binding and cofactor recruitment are possible determinants of the synthetic steroid YK11-dependent gene expression by androgen receptor in breast cancer MDA-MB 453 cells

被引:1
作者
Kanno, Yuichiro [1 ,2 ]
Saito, Nao [2 ]
Saito, Ryota [4 ]
Kosuge, Tomohiro [1 ]
Shizu, Ryota [1 ]
Yatsu, Tomofumi [2 ]
Hosaka, Takuomi [1 ]
Nemoto, Kiyomitsu [2 ]
Kato, Keisuke [3 ]
Yoshinari, Kouichi [1 ]
机构
[1] Univ Shizuoka, Sch Pharmaceut Sci, Lab Mol Toxicol, 52-1 Yada,Suruga Ku, Shizuoka 4228526, Japan
[2] Toho Univ, Fac Pharmaceut Sci, Dept Mol Toxicol, Miyama 2-2-1, Funabashi, Chiba 2748510, Japan
[3] Toho Univ, Fac Pharmaceut Sci, Dept Organ Chem, 2-2-1 Miyama, Funabashi, Chiba 2748510, Japan
[4] Toho Univ, Dept Chem, 2-2-1 Miyama, Funabashi, Chiba 2748510, Japan
基金
日本学术振兴会;
关键词
Nuclear receptor; Androgen receptor; Breast cancer; Selective androgen receptor modulator; PROTEIN-LIGAND DOCKING; MEDIATED REGULATION; FUNCTIONAL-ANALYSIS; NATURAL AGONIST; PROSTATE-CANCER; REGULATED GENE; ACTIVATION; DOMAIN; MUTATION; YK11;
D O I
10.1016/j.yexcr.2022.113333
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Recently, selective androgen receptor modulators (SARMs), which bind to AR and act in a tissue/effect-specific manner, have been developed, but the selective mechanism is not well understood. In this study, we investigated the selective mechanism using the synthetic steroid YK11, which showed AR-mediated gene-selective trans -activation. In the AR-positive human breast cancer MDA-MB-453 cells, different patterns of AR-mediated target gene expression and AR recruitment to their enhancer regions were observed between DHT and YK11. A docking study suggested the helices 11 and 12 was moved by the sterically hindered C17-group of YK11. Furthermore, the mutational studies of AR Gln902 and mammalian two-hybrid assays suggested different cofactor recruitment between DHT and YK11. The results of this study suggest that gene selective regulation by SARMs results from differential DNA-binding and/or cofactor recruitment by ligands. These results provide novel insights into the mechanism of action of SARMs.
引用
收藏
页数:10
相关论文
共 51 条
  • [11] Dependence of selective gene activation on the androgen receptor NH2- and COOH-terminal interaction
    He, B
    Lee, LW
    Minges, JT
    Wilson, EM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (28) : 25631 - 25639
  • [12] SOCS2 mediates the cross talk between androgen and growth hormone signaling in prostate cancer
    Iglesias-Gato, Diego
    Chuan, Yin-Choy
    Wikstrom, Pernilla
    Augsten, Sandra
    Jiang, Ning
    Niu, Yuanjie
    Seipel, Amanda
    Danneman, Daniela
    Vermeij, Marcel
    Fernandez-Perez, Leandro
    Jenster, Guido
    Egevad, Lars
    Norstedt, Gunnar
    Flores-Morales, Amilcar
    [J]. CARCINOGENESIS, 2014, 35 (01) : 24 - 33
  • [13] Improved Synthesis and Determination of the Biologically Active Diastereomer of YK11
    Kanno, Yuichiro
    Kusakabe, Taichi
    Saito, Nao
    Kikkawa, Shoko
    Takahashi, Keisuke
    Azumaya, Isao
    Nemoto, Kiyomitsu
    Kato, Keisuke
    [J]. MOLBANK, 2020, 2020 (02)
  • [14] Nigramide C Is a Natural Agonist of Human Pregnane X Receptor
    Kanno, Yuichiro
    Yatsu, Tomofumi
    Li, Wei
    Koike, Kazuo
    Inouye, Yoshio
    [J]. DRUG METABOLISM AND DISPOSITION, 2014, 42 (06) : 1084 - 1089
  • [15] Kanno Y, 2013, BIOL PHARM BULL, V36, P1460
  • [16] (17α,20E)-17,20-[(1-Methoxyethylidene)bis(oxy)]-3-oxo-19-norpregna-4,20-diene-21-carboxylic Acid Methyl Ester (YK11) Is a Partial Agonist of the Androgen Receptor
    Kanno, Yuichiro
    Hikosaka, Ritsuko
    Zhang, Shu-Yun
    Inoue, Yoshimi
    Nakahama, Takayuki
    Kato, Keisuke
    Yamaguchi, Akemi
    Tominaga, Nobuaki
    Kohra, Shinya
    Arizono, Koji
    Inouye, Yoshio
    [J]. BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2011, 34 (03) : 318 - 323
  • [17] Empirical Scoring Functions for Advanced Protein-Ligand Docking with PLANTS
    Korb, Oliver
    Stutzle, Thomas
    Exner, Thomas E.
    [J]. JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2009, 49 (01) : 84 - 96
  • [18] Expression and degradation of androgen receptor: Mechanism and clinical implication
    Lee, DK
    Chang, CS
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (09) : 4043 - 4054
  • [19] TBCRC 032 IB/II Multicenter Study: Molecular Insights to AR Antagonist and PI3K Inhibitor Efficacy in Patients with AR+ Metastatic Triple-Negative Breast Cancer
    Lehmann, Brian D.
    Abramson, Vandana G.
    Sanders, Melinda E.
    Mayer, Erica L.
    Haddad, Tufia C.
    Nanda, Rita
    Van Poznak, Catherine
    Storniolo, Anna Maria
    Nangia, Julie R.
    Gonzalez-Ericsson, Paula I.
    Sanchez, Violeta
    Johnson, Kimberly N.
    Abramson, Richard G.
    Chen, Sheau-Chiann
    Shyr, Yu
    Arteaga, Carlos L.
    Wolff, Antonio C.
    Pietenpol, Jennifer A.
    [J]. CLINICAL CANCER RESEARCH, 2020, 26 (09) : 2111 - 2123
  • [20] A role of the amino-terminal (N) and carboxyl-terminal (C) interaction in binding of androgen receptor to chromatin
    Li, JW
    Fu, JJ
    Toumazou, C
    Yoon, HG
    Wong, JM
    [J]. MOLECULAR ENDOCRINOLOGY, 2006, 20 (04) : 776 - 785